Frequent prostate-specific antigen screenings may lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men.
Conducting frequent prostate-specific antigen (PSA) screenings was found to lower the risk of metastasis at the time of diagnosis and lower mortality risk from prostate cancer among younger African American men, according to study data to be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.